Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies

Shelley S. Tworoger(Oregon Health & Science University), Susan E. Hankinson(University of Massachusetts Amherst), Dana E. Rollison(Moffitt Cancer Center), Lisa Kahle, A. Heather Eliassen(Brigham and Women's Hospital), Sabina Rinaldi(St. Elizabeth's Hospital), Ruth C. Travis(University of Oxford), Franco Berrino(Tumori Foundation), Anthony J. Alberg(Johns Hopkins University), Gillian Reeves(University of Oxford), Sabina Sieri(Fondazione G.B. Bietti), Paola Muti(Department of Public Health), Mitch Dowsett(Institute of Cancer Research), Renée T. Fortner(Norwegian Institute of Public Health), Aurelio Barricarte(Instituto de Salud Pública de Navarra), Joanne F. Dorgan, Elio Ríboli(Imperial College London), Louise A. Brinton(National Cancer Institute), Laure Dossus(World Health Organization - Lyon Office), Vittorio Krogh(Istituti di Ricovero e Cura a Carattere Scientifico), FZ Stanczyk, J Hoff man-Bolton, P H M Peeters(University Medical Center Utrecht), T J Key, D Trichopoulos, Kathy J. Helzlsouer(Mercy Medical Center), P N Appleby, R. Kaaks(Centre International de Recherche sur le Cancer), Kim Overvad(Aarhus University), George W. Comstock
The Lancet Oncology
July 24, 2013
Cited by 403


Related Papers